Erratum: Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington's disease (Molecular Therapy (2023) 31(6) (1661–1674), (S1525001623002629), (10.1016/j.ymthe.2023.05.006))

Daniel O'Reilly, Jillian Belgrad, Chantal Ferguson, Ashley Summers, Ellen Sapp, Cassandra McHugh, Ella Mathews, Adel Boudi, Julianna Buchwald, Socheata Ly, Dimas Moreno, Raymond Furgal, Eric Luu, Zachary Kennedy, Vignesh Hariharan, Kathryn Monopoli, X. William Yang, Jeffery Carroll, Marian DiFiglia, Neil AroninAnastasia Khvorova

Research output: Contribution to journalComment/debatepeer-review

1 Scopus citations

Abstract

(Molecular Therapy 31, 1661–1674; June 2023) In the originally published version of this article, the data for MSH2, PMS1, and PMS2 in Figure 6 were unintentionally duplicated. After reviewing the original data, the authors found that the MSH2 data had been accidentally copied and pasted into the PMS1 and PMS2 data cells during data analysis. The corrected figure has been provided below. The authors state that the conclusions of Figure 6 and the manuscript have not changed with this correction. This article has been corrected online, and the authors apologize for any confusion this may have caused.[Formula

Original languageEnglish (US)
Pages (from-to)3355-3356
Number of pages2
JournalMolecular Therapy
Volume31
Issue number11
DOIs
StatePublished - Nov 1 2023
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Erratum: Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington's disease (Molecular Therapy (2023) 31(6) (1661–1674), (S1525001623002629), (10.1016/j.ymthe.2023.05.006))'. Together they form a unique fingerprint.

Cite this